Target Details
| UniProt AC | P49841 |
|---|---|
| Gene Symbol | GSK3B |
| Protein Name | Glycogen synthase kinase-3 beta |
| Organism | Homo sapiens |
| Entry Name | |
| Organism Category | Human |
| Pfam Domains | PF00069 (Pkinase) |
Summary
- Multi-target molecules 2,206
- Clinical molecules 168
- Avg pChEMBL 7.19
KEGG Pathways (49)
- Alcoholic liver disease
- Alzheimer disease
- Axon guidance
- B cell receptor signaling pathway
- Basal cell carcinoma
- Breast cancer
- Cadherin signaling
- Cell cycle
- Chemokine signaling pathway
- Colorectal cancer
- Cushing syndrome
- Diabetic cardiomyopathy
- Dopaminergic synapse
- EGFR tyrosine kinase inhibitor resistance
- Endometrial cancer
- ErbB signaling pathway
- Focal adhesion
- Gastric cancer
- Growth hormone synthesis, secretion and action
- Hedgehog signaling pathway
- Hepatitis C
- Hepatocellular carcinoma
- Hippo signaling pathway
- Human cytomegalovirus infection
- Human papillomavirus infection
- IL-17 signaling pathway
- IgSF CAM signaling
- Insulin resistance
- Insulin signaling pathway
- Integrin signaling
- Kaposi sarcoma-associated herpesvirus infection
- Lipid and atherosclerosis
- Measles
- Melanogenesis
- Neurotrophin signaling pathway
- Non-alcoholic fatty liver disease
- PI3K-Akt signaling pathway
- Pathways in cancer
- Pathways of neurodegeneration - multiple diseases
- Prion disease
- Prolactin signaling pathway
- Prostate cancer
- Shigellosis
- Signaling pathways regulating pluripotency of stem cells
- T cell receptor signaling pathway
- Thyroid hormone signaling pathway
- Wnt signaling pathway
- Yersinia infection
- mTOR signaling pathway
Active Molecules (2,206)
| InChIKey | pChEMBL | Type | Targets | Clinical | |
|---|---|---|---|---|---|
WCCYEJYTLNWYCC
|
8.1 | IC50 | 9 | — | |
ZJVHTWKAZJOGEG
|
8.1 | IC50 | 3 | — | |
FTEYATGRXXBZBW
|
8.0 | Ki | 3 | — | |
MDJOZDXRTJEZTG
|
8.0 | IC50 | 2 | — | |
NAOKGBHDYHEYEO
|
8.0 | Ki | 3 | — | |
QJGILMHLEDGHMD
|
8.0 | IC50 | 2 | — | |
FFCNNDFVTQMOJL
|
8.0 | Ki | 3 | — | |
KBYBZFDPEVMQPA
|
8.0 | Ki | 3 | — | |
SLHCHYSNAVYFGV
|
8.0 | Ki | 3 | — | |
OHIOZVADSRNHCG
|
8.0 | IC50 | 2 | — | |
PCOQJVPTRXWWPP
|
8.0 | Ki | 3 | — | |
AXWDQRXGOKDXJT
|
8.0 | IC50 | 6 | — | |
BBVQJCVFIRYCMO
|
8.0 | Ki | 3 | — | |
DMOBQUUJDHIDIT
|
8.0 | Ki | 3 | — | |
HMMOYICZYQQKER
|
8.0 | Ki | 3 | — | |
AMFNSEGCJHUABD
|
8.0 | Ki | 3 | — | |
ATBAETXFFCOZOY
|
8.0 | IC50 | 39 | — | |
ATBAETXFFCOZOY
|
8.0 | IC50 | 10 | — | |
BLZGDFUGFILBJG
|
8.0 | IC50 | 2 | — | |
BOQORPXVPMXARS
|
8.0 | IC50 | 3 | Yes | |
CAGLPTUMBKISRZ
|
8.0 | IC50 | 2 | — | |
CALAEFSQWBJMDU
|
8.0 | Ki | 21 | — | |
CMIRYEYYRRGPKG
|
8.0 | IC50 | 3 | — | |
CWRTWFWDDAJOMG
|
8.0 | IC50 | 4 | Yes | |
DPDZHVCKYBCJHW
|
8.0 | IC50 | 11 | — | |
GBNWWXHUOVAUHT
|
8.0 | IC50 | 4 | Yes | |
IOYGZJJCJBOPDM
|
8.0 | Ki | 8 | — | |
JQBZJGHSPYGXKD
|
8.0 | Ki | 3 | — | |
KSDORXSBAJOQKH
|
8.0 | Ki | 3 | — | |
LBVIZFWUIQSZHP
|
8.0 | IC50 | 10 | — | |
MENDIXKFTXYTHJ
|
8.0 | IC50 | 2 | — | |
MHWHPWMWKYXCRJ
|
8.0 | Ki | 32 | — | |
MJCKUHBSAUHVJE
|
8.0 | Ki | 4 | — | |
NKTGKAVJSAUPCX
|
8.0 | IC50 | 3 | Yes | |
QBXUCZWIDBSQSN
|
8.0 | Ki | 3 | — | |
QTHCAAFKVUWAFI
|
8.0 | IC50 | 23 | — | |
SAZAEFLODZISSG
|
8.0 | IC50 | 4 | — | |
SSTMOSQZONYWBG
|
8.0 | IC50 | 2 | — | |
UDEOCTBZGZHOLA
|
8.0 | Ki | 3 | — | |
ULWKEYMEZWWCRY
|
8.0 | Ki | 5 | — | |
ULXFFBWWZLAHEB
|
8.0 | IC50 | 2 | — | |
XFWUTMHVDGPWLH
|
8.0 | Ki | 75 | — | |
YWMJEKUKEKXNSA
|
8.0 | IC50 | 2 | — | |
YWTBGJGMTBHQTM
|
8.0 | Ki | 65 | — | |
ZANNOGKZSUYAAD
|
8.0 | IC50 | 3 | Yes | |
JOQUYNZUHFIENL
|
8.0 | Ki | 3 | — | |
XFAMPLVKCPRSQK
|
8.0 | Ki | 3 | — | |
BQDCJPVNOJZMFF
|
8.0 | Ki | 3 | — | |
NDMGXHPNLBTFLK
|
8.0 | Ki | 3 | — | |
CZTOAWUSFLFOKS
|
8.0 | Ki | 3 | — |